Regenxbio (RGNX) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to -$65000.0.
- Regenxbio's Other Operating Expenses fell 7567.57% to -$65000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$958000.0, marking a year-over-year decrease of 10845.99%. This contributed to the annual value of -$865000.0 for FY2024, which is 11788.41% down from last year.
- Regenxbio's Other Operating Expenses amounted to -$65000.0 in Q3 2025, which was down 7567.57% from -$45000.0 recorded in Q2 2025.
- In the past 5 years, Regenxbio's Other Operating Expenses registered a high of $19.2 million during Q3 2021, and its lowest value of -$833000.0 during Q4 2024.
- Over the past 5 years, Regenxbio's median Other Operating Expenses value was $5.4 million (recorded in 2021), while the average stood at $6.3 million.
- As far as peak fluctuations go, Regenxbio's Other Operating Expenses skyrocketed by 2000800.0% in 2021, and later plummeted by 14411.76% in 2025.
- Regenxbio's Other Operating Expenses (Quarter) stood at $15.0 million in 2021, then tumbled by 64.09% to $5.4 million in 2022, then soared by 110.26% to $11.4 million in 2023, then crashed by 107.34% to -$833000.0 in 2024, then skyrocketed by 92.2% to -$65000.0 in 2025.
- Its Other Operating Expenses was -$65000.0 in Q3 2025, compared to -$45000.0 in Q2 2025 and -$15000.0 in Q1 2025.